Alpha Fusion Accelerates Astatine-based Drug Discovery with Series B Funding ...Middle East

OSAKA, Japan, Oct. 9, 2024 /PRNewswire/ -- Alpha Fusion, Inc. (CEO: Sunao Fujioka, headquartered in Kita-ku, Osaka), has raised a total of ¥1.02 billion through a Series B funding round. The round was led by SBI Investment Co., Ltd. and OSAKA University Venture Capital, with participation...

Hence then, the article about alpha fusion accelerates astatine based drug discovery with series b funding was published today ( Wednesday 09/10/2024 - 10:28 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Alpha Fusion Accelerates Astatine-based Drug Discovery with Series B Funding )

Also on site :

• Ro Khanna Calls for Charges After Israeli Settlers Detain Him in West Bank
• Prince Harry Shares How Meghan Markle and Their Kids Keep Princess Diana's Memory Alive on Her Birthday and Death Anniversary 
• The U.S. and Iran can’t agree on fully reopening the Strait of Hormuz. The solution could be straight out of the Old Testament